⟵ Back to Search Results

BGB-3111-LTE1

Enrolling by invitation

Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell Malignancies

Beigene Study ID info

BGB-3111-LTE1

ClinicalTrials.gov ID info

NCT04170283

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents